Tim, I knew you would appreciate Charm's views, and those of this board.

Not a fan of Erbitux myself, but if they are going to administer it then make sure they've done the gene testing on you to see if you're one of the ones that will benefit from it. Article here:
http://www.webmd.com/colorectal-cancer/news/20080602/gene-testing-predicts-response-to-erbitux

They can predict the 2/3's of patients it can possibly benefit. So if we are grading drugs, Erbitux is only going to possibly work on 66% of people, that's a D unless we are grading on a curve